Not quite, primaus72, P2b was run against Lucentis monotherapy only. No Eylea arm included back then.
Instead, COAST is the very first time sozinibercept formaly is being tested against Eylea monotherapy
- Forums
- ASX - By Stock
- Ann: Security Class Reinstatement to Quotation- OPTOB
Not quite, primaus72, P2b was run against Lucentis monotherapy...
-
- There are more pages in this discussion • 180 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OPT (ASX) to my watchlist
|
|||||
Last
54.5¢ |
Change
0.005(0.93%) |
Mkt cap ! $670.9M |
Open | High | Low | Value | Volume |
54.5¢ | 56.0¢ | 53.8¢ | $817.0K | 1.498M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 619 | 54.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
55.0¢ | 27532 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 619 | 0.540 |
1 | 21032 | 0.535 |
5 | 44799 | 0.530 |
3 | 41100 | 0.525 |
8 | 170959 | 0.520 |
Price($) | Vol. | No. |
---|---|---|
0.550 | 27532 | 3 |
0.555 | 21032 | 1 |
0.560 | 74976 | 3 |
0.565 | 5000 | 1 |
0.570 | 10149 | 1 |
Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online